The overall goal of the research program is to understand the regulation of serine proteases involved in inflammation and host defenses. An imbalance between serine protease activity and inhibition generates biochemical cascades that often establish and propagate the pathophysiological basis of a wide variety of diseases. We are studying a family of high molecular weight plasma and cellular proteins, the serpins--serine protease inhibitors, some of which have evolved the remarkable property of inhibiting these proteases with astonishingly fast rates. In particular, we are interested the regulation of human neutrophil elastase (HNE) because of its well documented role in inflammation. We will focus on the reaction between HNE and alpha1-protease inhibitor (sometimes referred to as alpha1- antitrypsin) which is physiologically the most important inhibitor of the enzyme. How serpins inhibit their target enzymes is only partially understood but is presumed to involve a series of exquisitely timed chemical and conformational steps. There are three critical features of the general inhibitory mechanism, 1) the recognition and binding event, 2) the initial chemical reaction in cleaving the scissile bond, i.e., acylation, of the serpin by the protease, 3) a conformational change in the serpin that starts to occur either prior to, or following, the acylation step leading to an alteration of the conformation of the enzyme. This last step results in the enzyme and serpin trapped in a covalent complex that prevents continued catalysis and release of free enzyme. Our approach to the problem of how a serpin recognizes, binds and then inhibits HNE is to systematically examine the basic structural and kinetic features of each step in the reaction pathway. We propose a structural model for each step and will test these models using combinations of analytical tools including rapid kinetic techniques, probes of chemical reactivity--pH and solvent isotope effects, and X-ray crystallographic and spectroscopic determinations of protein conformation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL050523-06A1
Application #
6045071
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1994-05-01
Project End
2004-09-30
Budget Start
1999-09-30
Budget End
2000-02-29
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Schechter, Norman M; Plotnick, Michael I (2004) Measurement of the kinetic parameters mediating protease-serpin inhibition. Methods 32:159-68
Que, Xuchu; Brinen, Linda S; Perkins, Penny et al. (2002) Cysteine proteinases from distinct cellular compartments are recruited to phagocytic vesicles by Entamoeba histolytica. Mol Biochem Parasitol 119:23-32
Plotnick, Michael I; Rubin, Harvey; Schechter, Norman M (2002) The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin. J Biol Chem 277:29927-35
Plotnick, Michael I; Samakur, Madhurika; Wang, Zhi Mei et al. (2002) Heterogeneity in serpin-protease complexes as demonstrated by differences in the mechanism of complex breakdown. Biochemistry 41:334-42
Estebanez-Perpina, E; Fuentes-Prior, P; Belorgey, D et al. (2000) Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue. Biol Chem 381:1203-14
Pereira, P J; Wang, Z M; Rubin, H et al. (1999) The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. J Mol Biol 286:163-73
Janciauskiene, S; Rubin, H; Lukacs, C M et al. (1998) Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate. J Biol Chem 273:28360-4
Wang, Z; Walter, M; Selwood, T et al. (1998) Recombinant expression of human mast cell proteases chymase and tryptase. Biol Chem 379:167-74
O'Malley, K M; Nair, S A; Rubin, H et al. (1997) The kinetic mechanism of serpin-proteinase complex formation. An intermediate between the michaelis complex and the inhibited complex. J Biol Chem 272:5354-9
Plotnick, M I; Schechter, N M; Wang, Z M et al. (1997) Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex. Biochemistry 36:14601-8

Showing the most recent 10 out of 14 publications